ASSOCIATION OF SOME POLYMORPHISMS IN IL4, NOD2 AND CCR5 GENESWITH CHILDHOOD ASTHMA
Abstract
BACKGROUND Asthma is most common serious chronic disease of childhood. Asthma is inflammatorydisease of respiratory tract of unknown etiology. As is usual in most complex diseases,also in asthma genetic and environmental factors participate together. More than 100candidate genes are connected with asthma for now, but each of them has only smallcontribution in the pathogenesis of the disease. METHODS We included 111 children with mild or moderate persistent asthma, aged between 5 and18 years. 76 of them were atopics and 35 had nonatopic asthma. We measured some basicclinical and laboratory parameters. Data from 77 healthy children served as a controlgroup. We genotyped polymorphisms CCR5-delta32, IL4 C-33T and NOD2 R702W. Wecompared allelic frequencies between groups with ?2 and Fischer’s exact test. With t test fortwo independent samples we studied influence of genotype on clinical and laboratoryparameters. RESULTS Patients with nonatopic asthma had significantly lower frequency of CCR5-delta32 allele(1.39 %), compared with control group (10 %), p = 0.016. In other two tested polymorphismswe didn’t found any significant differences in allelic frequencies between asthmatics andcontrols. We revealed no influence of genotype on clinical and laboratory parameters. CONCLUSIONS Delta32 mutation in CCR5 gene protects against nonatopic asthma. Polymorphisms C-33Tin IL4 gene and R702W in NOD2 gene are not associated with asthma. We didn’t detectany influence of tested polymorphisms on clinical and laboratory parameters. Results ofour study offer new insights into asthma pathogenesis and could contribute in the development of new strategies of asthma managementDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
